Skip to content
PaperFren

Infectious disease

Does COVID-19 raise healthcare use and costs for months afterwards?

Koumpias AM, Schwartzman D, Fleming O · BMC health services research · 2022

Open access · cc by · source: Europe PMC

After a COVID-19 diagnosis, adults kept using more healthcare and costing more each month for at least six months than they had before infection, while children returned close to their previous level.

How this study connects

Role on claims

Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.

Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.

Study at a glance

Design
Cohort — Retrospective within-patient before-after cohort using US insurance claims: monthly visits and costs in the 6 months before versus 6 months after a lab-confirmed COVID-19 diagnosis (February-October 2020), modelled with linear regression and monthly lead/lag terms, excluding pulmonary encounters.
N
N=250514 · 250,514 patients (from 3,006,168 medical claims) with six months of records before and after diagnosis; commercially insured, Medicare, Medicaid and uninsured patients.
Population
US patients of all ages with a lab-confirmed COVID-19 diagnosis between February and October 1, 2020, in a national claims database covering commercial, Medicare, Medicaid and HRSA-uninsured payers.
Outcome
Monthly healthcare visits and medical expenditures across ten service categories (inpatient, emergency, telemedicine, surgery, cardiology and others), overall and by age group.

Structured fields used in claim comparison tables when every cited study has a complete layer.

Inspect source passages

Does COVID-19 raise healthcare use and costs for months afterwards?

These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.

10 service categories were defined

We identified different types of outpatient and inpatient medical encounters based on current procedural terminology (CPT) codes and designated broader classifications to each service, creating 10 distinct and mutually exclusive categories using a standard method of classifying services by the Health Care Cost Institute.

2020 February to October diagnosis window

Our sample includes information on healthcare utilization and medical expenditures from January 1, 2019 through March 31, 2021 of patients with a lab-confirmed COVID-19 diagnosis from the beginning of the public health emergency in February 2020 through October 1, 2020.
Read passages in the original paper

Key findings

On average a COVID-19 diagnosis was associated with 0.7269 extra visits (roughly three-quarters of a visit) and $223.59 extra spending per month over the following six months, driven mainly by inpatient, emergency and surgical care, with smaller rises in telemedicine and cardiology. Use peaked in the diagnosis month and declined but did not return to pre-diagnosis levels; excess visits fell from 0.499 in the second month to 0.158 in the sixth. Children's excess use and costs essentially disappeared by month six, whereas all adult groups stayed above baseline, with people aged 45-64 having the largest excess costs.

Methodology

The researchers used de-identified US insurance claims to follow 250,514 people with lab-confirmed COVID-19 diagnosed between February and October 2020, comparing each person's monthly healthcare use and spending in the six months before diagnosis with the six months after. They grouped services into ten categories such as inpatient, emergency, telemedicine and cardiology, deliberately leaving out lung-related visits, and adjusted for age, sex, insurance type and local socio-economic factors. Month-by-month models then estimated 'excess' use and cost by pairing each post-diagnosis month with its matching pre-diagnosis month.

Limitations

There was no comparison group of people without COVID-19, so the authors stress the results are descriptive and not causal; rising use could reflect other health problems or pandemic-era changes in care. The claims come from providers, so some care is missing and estimates are lower bounds, and mortality was not recorded, so likely deaths were excluded, possibly biasing older groups. Lung-related visits were deliberately excluded, the sample was diagnosed early in the pandemic before vaccines, and the study cannot tell whether extra care was for long-COVID symptoms or pre-existing conditions.

Related papers in this topic

Same topic cluster — not a recommendation engine.